Metamark Genetics announced that Shawn Marcell will succeed Michael Kauffman as the company's new president and CEO. Kauffman had been serving as the firm's interim executive director after Mark Straley resigned as president and CEO last year. Kauffman will remain on Metamark's board of directors.
Before joining Metamark as its CEO, Marcell was general manager of Hologic's Lifecodes subsidiary, which was acquired by Immucor. He has also headed commercial operations at Sequenom and served as president and CEO of Sequenom subsidary SensiGen.
Nanosphere announced the appointment of Ken Bahk as its chief strategy officer, a new position, and that CTO Tim Patno and board member Chad Mirkin will be leaving the company.
Bahk was part of Nanosphere's initial team, and served with the company until 2008. In his new role at Nanosphere, he will be responsible for driving strategic plans and revenues in molecular diagnostics.
He is currently a director of investments at Lurie Investments and previously served as the chair of strategic opportunities for the Association for Molecular Pathology.
Warren Kocmond will join Cepheid on May 6 as its executive VP of global operations, the company disclosed during its first-quarter earnings call. Kocmond is currently VP of global operations for Lam Research, and has previously served as executive VP of memory products at Verigy; CEO of Electroglas; and senior VP of global operations at Affymetrix.